Augmented Pain and Inflammation with Obesity: A Role for the Pro-Inflammatory Cytokine Visfatin
Augmented Pain and Inflammation with Obesity: A Role for the Pro-Inflammatory Cytokine Visfatin
Review Data
Q: Is the topic relevant to the journal area of interest? Is it contemporary and interesting for
researchers?
A: Very good
Abstract & Keywords
Q: Are all required components included in the abstract? Are the keywords appropriately chosen?
A: Excellent
Goal
Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?
A: Good
Structure
Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?
A: Very good
Tools and Methods
Q: Are methods the author uses adequate and well used?
A: Very good
Discussion & Conclusion
Q: Is it related to the results presented before? Do you consider them as coherent?
A: Good
Comments:
The study is well designed and executed. The Methods and Results are adequately described. The Results suggest that blocking visfatin may be a promising therapeutic target for treatment of pain by attenuating the inflammatory cytokine cascade associated with inflammatory conditions, including obesity. The Discussion offers a thorough and detailed analysis of the findings of the present study taking all the relevant literature into account. It aptly recommends further studies to confirm if anti-visfatin therapies can alleviate inflammatory pain and the increased incidence of painful conditions with obesity.
Literature
Q: Does the author utilize relevant literature?
A: Good
Author's knowledge
Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?
A: Good
Length
Q: Is the length of the paper adequate to the significance of the topic? Do you suggest shortening the paper without losing its value?
A: Good
Figures & Tables
Q: Does the author use them suitably? Are legend and notations clear?
A: Very good
Comments:
In both Figure legends of Figure 2 & 3 the sentence, "Paw oedema is represented as mean % change in paw volume from the contralateral paw at 6 and 24 hours" should correspond to Figure numbering 2E and 3E respectively instead of 2D and 3D.
Writing style
Q: Is it clear and understandable?
A: Very good
Further comments on the paper
Comments: This study characterizes pain and inflammation, and levels of the pro-inflammatory cytokine visfatin, in a rodent model of obesity, and investigates whether treatment with the visfatin inhibitor, FK866, has anti-inflammatory and/or analgesic effects in normal and obese rats. The study is of significance as it shows that treatment with FK866 is effective in reducing carrageenan-induced hyperalgesia and paw oedema in both normal diet (ND)-fed and high fat diet (HFD)-fed rats, suggesting that FK866 has anti-inflammatory and analgesic properties. The results further indicate a key role for visfatin in modulating inflammatory pain.
Q: Would you recommend this manuscript for further publication?
A: Yes - Suitable to be published
If you have any questions and clarifications you can write to the journal.
Thanks,
Science Repository Team
Science Repository This email is restricted to the intended user. |
Science Repository - Support |
Author Info
Corresponding Author
Sharron DolanDepartment of Biological and Biomedical Sciences, Glasgow Caledonian University, Glasgow, UK
Article Info
Article Type
Research ArticlePublication history
Received: Thu 08, Jul 2021Accepted: Sat 24, Jul 2021
Published: Mon 09, Aug 2021
Copyright
© 2023 Sharron Dolan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.NNB.2021.03.01